CATIS: Immediate reduction in blood pressure demonstrated no benefit in acute stroke

It is shown that hypertension is associated with the occurrence of stroke but immediate treatment for an acute stroke itself is unclear. This study randomized 4071 acute stroke patients enrolled in an anti-hypertensive treatment (systolic pressure reduction by 10-25 % in the first 24 hours) versus control (stopping all antihypertensive drugs). 

The study included patients experiencing stroke within the first 48 hours and had a systolic pressure between 140 and 220 mm Hg without evidence of target organ damage (aortic dissection, myocardial ischemia, etc.) The primary end point was a composite of death and severe disability     (modified Rankin scale ≥ 3 ) at 14 days or at the time of discharge that was similar between the two groups (OR 1.00 , 95% CI 0.88 – 1.14, p = .98 ) . At 3 months the results were also identical between the two groups.

Conclusion:

In patients experiencing an acute stroke immediate reduction in blood pressure compared with the absence of anti-hypertensive treatment did not reduce the incidence of death or severe disability.

Original article

1_jiang_he_slides
Jiang He
2013-11-17

Original title: CATIS trial: Blood Pressure Reduction Among Ischemic Stroke Patients: a Randomized Controlled Clinical Trial

More articles by this author

Mild hypothermia in pre-hospital phase after cardiac arrest

Hypothermia in the hospital phase at 32-34 ° C improves neurological outcome in patients resuscitated after ventricular fibrillation out of the hospital environment. In...

TTM: Hypothermia after cardiac arrest does not offer benefits

Previous studies evaluated therapeutic hypothermia (32 ° C to 34 ° C for 12-24 hours) in patients who remain unconscious after resuscitation from cardiac...

NIAMI: Nitroprusside infusion prior to primary angioplasty

The phenomenon of reperfusion injury is responsible for 50 % of the final infarct size. Several pharmacological and non-pharmacological agents administered before or during...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...